Search

everythinglearnresearchcommunity

for

Search:↓

The document says homoeopathic treatments are good for hair regrowth in alopecia areata but doesn't give proof.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Two siblings both had a rare case of alopecia areata at the same time.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.